Vascular Risk Factors Have Little Impact on Efficacy of ESD for Meniere Disease
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
THURSDAY, July 6, 2023 -- For patients with Meniere disease, vascular risk factors have little effect on the efficacy of endolymphatic sac decompression (ESD) surgery, according to a study published online May 25 in the Frontiers of Neurology.
Yiling Li, from the Fifth School of Clinical Medicine in Hefei, China, and colleagues examined the effect of vascular risk factors on the outcomes of ESD surgery in a study involving 56 patients with Meniere disease. Based on the preoperative 10-year atherosclerotic cardiovascular diseases risk classification, patients' vascular risk factors were assessed. The low-risk group included patients with no or low risk, while the high-risk group included those with medium, high, or very high risk.
The researchers found that 78.95 and 81.08 percent of patients from the low- and high-risk groups, respectively, demonstrated at least grade B vertigo control after ESD, with no statistically significant difference noted between the groups. In both groups, the postoperative functional disability scores were significantly lower than those before surgery, with a median decrease of 2 points in both groups.
"ESD may effectively reduce vertigo attacks and dysfunction in patients with Meniere disease, and its efficacy is not reduced by an increase in vascular risk factors," the authors write. "The findings from this study may increase confidence regarding the use of ESD in patients with Meniere disease, thereby preventing unnecessary destructive surgeries."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
Triple Semicircular Canal Occlusion + Endolymphatic Sac Decompression Alleviates Vertigo
WEDNESDAY, June 5, 2024 -- Triple semicircular canal occlusion combined with endolymphatic sac decompression (ESD) may be an effective treatment option for managing frequent...
Cochlear Implants Aid Meniere Disease Outcomes
TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...
No Causal Association Seen for Meniere Disease, Migraine
MONDAY, June 3, 2024 -- Migraine is not a risk factor for Meniere disease (MD), nor is MD a risk factor for migraine, according to a study published online May 8 in Frontiers in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.